PharmacotherapeuticsNforNAdvancedNPracticeNNurseNPrescribersN5thNEditionNWooNRobinsonNTestN
Bank
, PharmacotherapeuticsNforNAdvancedNPracticeNNurseNPrescribersN5thNEditionNWooNRobinsonNTestN
Bank
Pharmacotherapeutics N
forNAdvancedNPracticeNNurseNPrescribersN5thNEditionNWooNRobinsonNTestNBank
ChapterN1.NTheNRoleNofNtheNNurseNPractitione
rNMultipleNChoice
IdentifyNtheNchoiceNthatNbestNcompletesNtheNstatementNorNanswersNtheNquestion.
N NN 1.NNurseNpractitionerNprescriptiveNauthorityNisNregulatedN by:
1. TheNNationalNCouncilNofNStateNBoardsNofNNursing
2. TheNU.S.NDrugNEnforcementNAdministration
3. TheNStateNBoardNofNNursingNforNeachNstate
4. TheNStateNBoardNofNPharmacy
N
NN 2.NTheNbenefitsNtoNtheNpatientNofNhavingNanNAdvancedNPracticeNRegistered NNurseN(APRN)Np
rescriberNinclude:
1. NursesNknowNmoreNaboutNPharmacologyNthanNotherNprescribersNbecauseNtheyNtakeN
itNbothNinNtheirNbasicNnursingNprogramNandNinNtheirNAPRNNprogram.
2. NursesNcareNforNtheNpatientNfromNaNholisticNapproachNandNincludeNtheNpatientNin
decisionNmakingNregardingNtheirNcare.
3. APRNsNareNlessNlikelyNtoNprescribeNnarcoticsNandNotherNcontrolledNsubstances.
4. APRNsNareNableNtoNprescribeNindependentlyNinNallNstates,NwhereasNaNphysician
’sNassistantNneedsNtoNhaveNaNphysicianNsupervisingNtheirNpractice.
N NN 3.NClinicalNjudgmentNinNprescribingN includes:
1. FactoringNinNtheNcostNtoNtheNpatientNofNtheNmedicationNprescribed
2. AlwaysNprescribingNtheNnewestNmedicationNavailableNforNtheNdiseaseNprocess
3. HandingNoutNdrugNsamplesNtoNpoorNpatients
4. PrescribingNallNgenericNmedicationsNtoNcutNcosts
N NN 4.NCriteriaNforNchoosingNanNeffectiveNdrugNforNaNdisorderNinclude:
1. AskingNtheNpatientNwhatNdrugNtheyNthinkNwouldNworkNbestNforNthem
2. ConsultingNnationallyNrecognizedNguidelinesNforNdiseaseNmanagement
3. PrescribingNmedicationsNthatNareNavailableNasNsamplesNbeforeNwritingNaNprescription
4. FollowingNU.S.NDrugNEnforcementNAdministrationNguidelinesNforNprescribing
N NN 5.NNurseNpractitionerNpracticeNmayNthriveNunderNhealth-careNreformNbecauseNof:
1. TheNdemonstratedNabilityNofNnurseNpractitionersNtoNcontrolNcostsNandNimproveNpatie
ntNoutcomes
2. TheNfactNthatNnurseNpractitionersNwillNbeNableNtoNpracticeNindependently
3. TheNfactNthatNnurseNpractitionersNwillNhaveNfullNreimbursementNunderNhealth-
careNreform
4. TheNabilityNtoNshiftNaccountabilityNforNMedicaidNtoNtheNstateNlevel
,PharmacotherapeuticsNforNAdvancedNPracticeNNurseNPrescribersN5thNEditionNWooNRobinsonNTestN
Bank
, PharmacotherapeuticsNforNAdvancedNPracticeNNurseNPrescribersN5thNEditionNWooNRobinsonNTestN
Bank
ChapterN1.NTheNRoleNofNtheNNurseNPractitione
rNAnswerNSection
MULTIPLENCHOICE
1. ANS:NNN 3 PTS:N 1
2. ANS:NNN 2 PTS:N 1
3. ANS:NNN 1 PTS:N 1
4. ANS:NNN 2 PTS:N 1
5. ANS:NNN 1 PTS:N 1
ChapterN2.NReviewNofNBasicNPrinciplesNofNPharmacolog
yNMultipleNChoice
IdentifyNtheNchoiceNthatNbestNcompletesNtheNstatementNorNanswersNtheNquestion.
N
NN 1.NANpatient’sNnutritionalNintakeNandNlaboratoryNresultsNreflectNhypoalbuminemia.NThisNisNc
riticalNtoNprescribingNbecause:
1. DistributionNofNdrugsNtoNtargetNtissueNmayNbeNaffected.
2. TheNsolubilityNofNtheNdrugNwillNnotNmatchNtheNsiteNofNabsorption.
3. ThereNwillNbeNlessNfreeNdrugNavailableNtoNgenerateNanNeffect.
4. DrugsNboundNtoNalbuminNareNreadilyNexcretedNbyNtheNkidneys.
N NN 2.NDrugsNthatNhaveNaNsignificantNfirst-passN effect:
1. MustNbeNgivenNbyNtheNenteralN(oral)NrouteNonly
2. BypassNtheNhepaticNcirculation
3. AreNrapidlyNmetabolizedNbyNtheNliverNandNmayNhaveNlittleNifNanyNdesiredNaction
4. AreNconvertedNbyNtheNliverNtoNmoreNactiveNandNfat-solubleNforms
N NN 3.NTheNrouteNofNexcretionNofNaNvolatileNdrugNwillNlikelyNbeN the:
1. Kidneys
2. Lungs
3. BileNandNfeces
4. Skin
N
NN 4.NMedroxyprogesteroneN(DepoNProvera)NisNprescribedNintramuscularlyN(IM)NtoNcreateNa
NstorageNreservoirNofNtheNdrug.NStorageNreservoirs:
1. AssureNthatNtheNdrugNwillNreachNitsNintendedNtargetNtissue
2. AreNtheNreasonNforNgivingNloadingNdoses
3. IncreaseNtheNlengthNofNtimeNaNdrugNisNavailableNandNactive
4. AreNmostNcommonNinNcollagenNtissues
N NN 5.NTheNNPNchoosesNtoNgiveNcephalexinNeveryN8NhoursNbasedNonNknowledgeNofNtheNdrug’s:
1. PropensityNtoNgoNtoNtheNtargetNreceptor
2. BiologicalNhalf-life
3. Pharmacodynamics
4. SafetyNandNsideNeffects
Bank
, PharmacotherapeuticsNforNAdvancedNPracticeNNurseNPrescribersN5thNEditionNWooNRobinsonNTestN
Bank
Pharmacotherapeutics N
forNAdvancedNPracticeNNurseNPrescribersN5thNEditionNWooNRobinsonNTestNBank
ChapterN1.NTheNRoleNofNtheNNurseNPractitione
rNMultipleNChoice
IdentifyNtheNchoiceNthatNbestNcompletesNtheNstatementNorNanswersNtheNquestion.
N NN 1.NNurseNpractitionerNprescriptiveNauthorityNisNregulatedN by:
1. TheNNationalNCouncilNofNStateNBoardsNofNNursing
2. TheNU.S.NDrugNEnforcementNAdministration
3. TheNStateNBoardNofNNursingNforNeachNstate
4. TheNStateNBoardNofNPharmacy
N
NN 2.NTheNbenefitsNtoNtheNpatientNofNhavingNanNAdvancedNPracticeNRegistered NNurseN(APRN)Np
rescriberNinclude:
1. NursesNknowNmoreNaboutNPharmacologyNthanNotherNprescribersNbecauseNtheyNtakeN
itNbothNinNtheirNbasicNnursingNprogramNandNinNtheirNAPRNNprogram.
2. NursesNcareNforNtheNpatientNfromNaNholisticNapproachNandNincludeNtheNpatientNin
decisionNmakingNregardingNtheirNcare.
3. APRNsNareNlessNlikelyNtoNprescribeNnarcoticsNandNotherNcontrolledNsubstances.
4. APRNsNareNableNtoNprescribeNindependentlyNinNallNstates,NwhereasNaNphysician
’sNassistantNneedsNtoNhaveNaNphysicianNsupervisingNtheirNpractice.
N NN 3.NClinicalNjudgmentNinNprescribingN includes:
1. FactoringNinNtheNcostNtoNtheNpatientNofNtheNmedicationNprescribed
2. AlwaysNprescribingNtheNnewestNmedicationNavailableNforNtheNdiseaseNprocess
3. HandingNoutNdrugNsamplesNtoNpoorNpatients
4. PrescribingNallNgenericNmedicationsNtoNcutNcosts
N NN 4.NCriteriaNforNchoosingNanNeffectiveNdrugNforNaNdisorderNinclude:
1. AskingNtheNpatientNwhatNdrugNtheyNthinkNwouldNworkNbestNforNthem
2. ConsultingNnationallyNrecognizedNguidelinesNforNdiseaseNmanagement
3. PrescribingNmedicationsNthatNareNavailableNasNsamplesNbeforeNwritingNaNprescription
4. FollowingNU.S.NDrugNEnforcementNAdministrationNguidelinesNforNprescribing
N NN 5.NNurseNpractitionerNpracticeNmayNthriveNunderNhealth-careNreformNbecauseNof:
1. TheNdemonstratedNabilityNofNnurseNpractitionersNtoNcontrolNcostsNandNimproveNpatie
ntNoutcomes
2. TheNfactNthatNnurseNpractitionersNwillNbeNableNtoNpracticeNindependently
3. TheNfactNthatNnurseNpractitionersNwillNhaveNfullNreimbursementNunderNhealth-
careNreform
4. TheNabilityNtoNshiftNaccountabilityNforNMedicaidNtoNtheNstateNlevel
,PharmacotherapeuticsNforNAdvancedNPracticeNNurseNPrescribersN5thNEditionNWooNRobinsonNTestN
Bank
, PharmacotherapeuticsNforNAdvancedNPracticeNNurseNPrescribersN5thNEditionNWooNRobinsonNTestN
Bank
ChapterN1.NTheNRoleNofNtheNNurseNPractitione
rNAnswerNSection
MULTIPLENCHOICE
1. ANS:NNN 3 PTS:N 1
2. ANS:NNN 2 PTS:N 1
3. ANS:NNN 1 PTS:N 1
4. ANS:NNN 2 PTS:N 1
5. ANS:NNN 1 PTS:N 1
ChapterN2.NReviewNofNBasicNPrinciplesNofNPharmacolog
yNMultipleNChoice
IdentifyNtheNchoiceNthatNbestNcompletesNtheNstatementNorNanswersNtheNquestion.
N
NN 1.NANpatient’sNnutritionalNintakeNandNlaboratoryNresultsNreflectNhypoalbuminemia.NThisNisNc
riticalNtoNprescribingNbecause:
1. DistributionNofNdrugsNtoNtargetNtissueNmayNbeNaffected.
2. TheNsolubilityNofNtheNdrugNwillNnotNmatchNtheNsiteNofNabsorption.
3. ThereNwillNbeNlessNfreeNdrugNavailableNtoNgenerateNanNeffect.
4. DrugsNboundNtoNalbuminNareNreadilyNexcretedNbyNtheNkidneys.
N NN 2.NDrugsNthatNhaveNaNsignificantNfirst-passN effect:
1. MustNbeNgivenNbyNtheNenteralN(oral)NrouteNonly
2. BypassNtheNhepaticNcirculation
3. AreNrapidlyNmetabolizedNbyNtheNliverNandNmayNhaveNlittleNifNanyNdesiredNaction
4. AreNconvertedNbyNtheNliverNtoNmoreNactiveNandNfat-solubleNforms
N NN 3.NTheNrouteNofNexcretionNofNaNvolatileNdrugNwillNlikelyNbeN the:
1. Kidneys
2. Lungs
3. BileNandNfeces
4. Skin
N
NN 4.NMedroxyprogesteroneN(DepoNProvera)NisNprescribedNintramuscularlyN(IM)NtoNcreateNa
NstorageNreservoirNofNtheNdrug.NStorageNreservoirs:
1. AssureNthatNtheNdrugNwillNreachNitsNintendedNtargetNtissue
2. AreNtheNreasonNforNgivingNloadingNdoses
3. IncreaseNtheNlengthNofNtimeNaNdrugNisNavailableNandNactive
4. AreNmostNcommonNinNcollagenNtissues
N NN 5.NTheNNPNchoosesNtoNgiveNcephalexinNeveryN8NhoursNbasedNonNknowledgeNofNtheNdrug’s:
1. PropensityNtoNgoNtoNtheNtargetNreceptor
2. BiologicalNhalf-life
3. Pharmacodynamics
4. SafetyNandNsideNeffects
